nodes	percent_of_prediction	percent_of_DWPC	metapath
Latanoprost—SLC22A1—hematologic cancer	0.477	1	CbGaD
Latanoprost—SLC22A1—Cytarabine—hematologic cancer	0.0764	0.356	CbGbCtD
Latanoprost—SLC22A1—Cladribine—hematologic cancer	0.0721	0.336	CbGbCtD
Latanoprost—SLC22A1—Imatinib—hematologic cancer	0.0663	0.309	CbGbCtD
Latanoprost—PTGFR—ovarian follicle—hematologic cancer	0.0392	0.717	CbGeAlD
Latanoprost—PTGFR—lung—hematologic cancer	0.00274	0.0503	CbGeAlD
Latanoprost—SLCO2B1—hematopoietic system—hematologic cancer	0.00261	0.0477	CbGeAlD
Latanoprost—PTGFR—testis—hematologic cancer	0.00259	0.0474	CbGeAlD
Latanoprost—PTGFR—lymph node—hematologic cancer	0.00188	0.0344	CbGeAlD
Latanoprost—SLC22A1—blood—hematologic cancer	0.00165	0.0302	CbGeAlD
Latanoprost—SLCO2B1—lung—hematologic cancer	0.00151	0.0277	CbGeAlD
Latanoprost—SLCO2B1—testis—hematologic cancer	0.00143	0.0262	CbGeAlD
Latanoprost—SLCO2B1—lymph node—hematologic cancer	0.00104	0.019	CbGeAlD
Latanoprost—Iloprost—PDE4B—hematologic cancer	0.000983	1	CrCbGaD
Latanoprost—Headache—Nilotinib—hematologic cancer	0.000101	0.000517	CcSEcCtD
Latanoprost—Dermatitis—Imatinib—hematologic cancer	0.000101	0.000517	CcSEcCtD
Latanoprost—Oedema—Gemcitabine—hematologic cancer	0.000101	0.000516	CcSEcCtD
Latanoprost—Eye pain—Doxorubicin—hematologic cancer	0.000101	0.000515	CcSEcCtD
Latanoprost—Skin disorder—Mitoxantrone—hematologic cancer	0.000101	0.000514	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Alitretinoin—hematologic cancer	0.000101	0.000514	CcSEcCtD
Latanoprost—Headache—Imatinib—hematologic cancer	0.000101	0.000514	CcSEcCtD
Latanoprost—Dizziness—Vinblastine—hematologic cancer	0.0001	0.000511	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Ifosfamide—hematologic cancer	9.95e-05	0.000508	CcSEcCtD
Latanoprost—Rash—Cladribine—hematologic cancer	9.94e-05	0.000508	CcSEcCtD
Latanoprost—Dyspnoea—Carmustine—hematologic cancer	9.94e-05	0.000508	CcSEcCtD
Latanoprost—Dermatitis—Cladribine—hematologic cancer	9.93e-05	0.000508	CcSEcCtD
Latanoprost—Pain—Thalidomide—hematologic cancer	9.93e-05	0.000507	CcSEcCtD
Latanoprost—Nervous system disorder—Gemcitabine—hematologic cancer	9.9e-05	0.000506	CcSEcCtD
Latanoprost—Pruritus—Lenalidomide—hematologic cancer	9.9e-05	0.000506	CcSEcCtD
Latanoprost—Headache—Cladribine—hematologic cancer	9.88e-05	0.000505	CcSEcCtD
Latanoprost—Dyspnoea—Alitretinoin—hematologic cancer	9.85e-05	0.000503	CcSEcCtD
Latanoprost—Diplopia—Epirubicin—hematologic cancer	9.83e-05	0.000502	CcSEcCtD
Latanoprost—Vision blurred—Prednisolone—hematologic cancer	9.82e-05	0.000502	CcSEcCtD
Latanoprost—Skin disorder—Gemcitabine—hematologic cancer	9.81e-05	0.000501	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—hematologic cancer	9.75e-05	0.000498	CcSEcCtD
Latanoprost—Dyspnoea—Ifosfamide—hematologic cancer	9.73e-05	0.000497	CcSEcCtD
Latanoprost—Discomfort—Cisplatin—hematologic cancer	9.7e-05	0.000496	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Vincristine—hematologic cancer	9.7e-05	0.000495	CcSEcCtD
Latanoprost—Erythema—Triamcinolone—hematologic cancer	9.58e-05	0.00049	CcSEcCtD
Latanoprost—Pain—Carmustine—hematologic cancer	9.54e-05	0.000487	CcSEcCtD
Latanoprost—Headache—Vinblastine—hematologic cancer	9.47e-05	0.000484	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Methotrexate—hematologic cancer	9.46e-05	0.000483	CcSEcCtD
Latanoprost—Pain—Alitretinoin—hematologic cancer	9.45e-05	0.000483	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Mitoxantrone—hematologic cancer	9.44e-05	0.000482	CcSEcCtD
Latanoprost—Oedema—Cisplatin—hematologic cancer	9.41e-05	0.000481	CcSEcCtD
Latanoprost—Pain—Ifosfamide—hematologic cancer	9.34e-05	0.000477	CcSEcCtD
Latanoprost—Back pain—Triamcinolone—hematologic cancer	9.27e-05	0.000474	CcSEcCtD
Latanoprost—Dizziness—Lenalidomide—hematologic cancer	9.25e-05	0.000473	CcSEcCtD
Latanoprost—Dyspnoea—Irinotecan—hematologic cancer	9.24e-05	0.000472	CcSEcCtD
Latanoprost—Dyspnoea—Mitoxantrone—hematologic cancer	9.24e-05	0.000472	CcSEcCtD
Latanoprost—Nervous system disorder—Cisplatin—hematologic cancer	9.23e-05	0.000472	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Gemcitabine—hematologic cancer	9.2e-05	0.00047	CcSEcCtD
Latanoprost—Skin disorder—Cisplatin—hematologic cancer	9.14e-05	0.000467	CcSEcCtD
Latanoprost—Dizziness—Hydroxyurea—hematologic cancer	9.12e-05	0.000466	CcSEcCtD
Latanoprost—Pruritus—Bortezomib—hematologic cancer	9.11e-05	0.000465	CcSEcCtD
Latanoprost—Pain—Vincristine—hematologic cancer	9.1e-05	0.000465	CcSEcCtD
Latanoprost—Diplopia—Doxorubicin—hematologic cancer	9.1e-05	0.000465	CcSEcCtD
Latanoprost—Asthma—Methotrexate—hematologic cancer	9.08e-05	0.000464	CcSEcCtD
Latanoprost—Rash—Melphalan—hematologic cancer	9.07e-05	0.000463	CcSEcCtD
Latanoprost—Dermatitis—Melphalan—hematologic cancer	9.06e-05	0.000463	CcSEcCtD
Latanoprost—Pruritus—Bleomycin—hematologic cancer	9.04e-05	0.000462	CcSEcCtD
Latanoprost—Dyspnoea—Gemcitabine—hematologic cancer	9e-05	0.00046	CcSEcCtD
Latanoprost—Chest pain—Etoposide—hematologic cancer	8.99e-05	0.00046	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Etoposide—hematologic cancer	8.93e-05	0.000456	CcSEcCtD
Latanoprost—Pruritus—Vinorelbine—hematologic cancer	8.89e-05	0.000454	CcSEcCtD
Latanoprost—Discomfort—Etoposide—hematologic cancer	8.89e-05	0.000454	CcSEcCtD
Latanoprost—Pain—Mitoxantrone—hematologic cancer	8.86e-05	0.000453	CcSEcCtD
Latanoprost—Pain—Irinotecan—hematologic cancer	8.86e-05	0.000453	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Epirubicin—hematologic cancer	8.86e-05	0.000452	CcSEcCtD
Latanoprost—Rash—Lenalidomide—hematologic cancer	8.82e-05	0.000451	CcSEcCtD
Latanoprost—Dermatitis—Lenalidomide—hematologic cancer	8.81e-05	0.00045	CcSEcCtD
Latanoprost—Discomfort—Prednisolone—hematologic cancer	8.77e-05	0.000448	CcSEcCtD
Latanoprost—Headache—Lenalidomide—hematologic cancer	8.76e-05	0.000448	CcSEcCtD
Latanoprost—Rash—Hydroxyurea—hematologic cancer	8.7e-05	0.000444	CcSEcCtD
Latanoprost—Erythema—Betamethasone—hematologic cancer	8.69e-05	0.000444	CcSEcCtD
Latanoprost—Erythema—Dexamethasone—hematologic cancer	8.69e-05	0.000444	CcSEcCtD
Latanoprost—Dermatitis—Hydroxyurea—hematologic cancer	8.69e-05	0.000444	CcSEcCtD
Latanoprost—Headache—Hydroxyurea—hematologic cancer	8.64e-05	0.000441	CcSEcCtD
Latanoprost—Pain—Gemcitabine—hematologic cancer	8.63e-05	0.000441	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Cisplatin—hematologic cancer	8.57e-05	0.000438	CcSEcCtD
Latanoprost—Connective tissue disorder—Prednisone—hematologic cancer	8.55e-05	0.000437	CcSEcCtD
Latanoprost—Dizziness—Bortezomib—hematologic cancer	8.51e-05	0.000435	CcSEcCtD
Latanoprost—Oedema—Prednisolone—hematologic cancer	8.5e-05	0.000434	CcSEcCtD
Latanoprost—Asthma—Epirubicin—hematologic cancer	8.5e-05	0.000434	CcSEcCtD
Latanoprost—Pruritus—Thiotepa—hematologic cancer	8.49e-05	0.000434	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Methotrexate—hematologic cancer	8.44e-05	0.000431	CcSEcCtD
Latanoprost—Dyspnoea—Cisplatin—hematologic cancer	8.39e-05	0.000429	CcSEcCtD
Latanoprost—Skin disorder—Etoposide—hematologic cancer	8.38e-05	0.000428	CcSEcCtD
Latanoprost—Dizziness—Vinorelbine—hematologic cancer	8.31e-05	0.000425	CcSEcCtD
Latanoprost—Angina pectoris—Epirubicin—hematologic cancer	8.28e-05	0.000423	CcSEcCtD
Latanoprost—Pruritus—Thalidomide—hematologic cancer	8.21e-05	0.00042	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Doxorubicin—hematologic cancer	8.19e-05	0.000419	CcSEcCtD
Latanoprost—Bronchitis—Epirubicin—hematologic cancer	8.17e-05	0.000418	CcSEcCtD
Latanoprost—Rash—Bortezomib—hematologic cancer	8.12e-05	0.000415	CcSEcCtD
Latanoprost—Dermatitis—Bortezomib—hematologic cancer	8.11e-05	0.000414	CcSEcCtD
Latanoprost—Headache—Bortezomib—hematologic cancer	8.06e-05	0.000412	CcSEcCtD
Latanoprost—Discomfort—Triamcinolone—hematologic cancer	8.06e-05	0.000412	CcSEcCtD
Latanoprost—Rash—Bleomycin—hematologic cancer	8.05e-05	0.000411	CcSEcCtD
Latanoprost—Pain—Cisplatin—hematologic cancer	8.05e-05	0.000411	CcSEcCtD
Latanoprost—Dermatitis—Bleomycin—hematologic cancer	8.05e-05	0.000411	CcSEcCtD
Latanoprost—Dizziness—Thiotepa—hematologic cancer	7.94e-05	0.000406	CcSEcCtD
Latanoprost—Rash—Vinorelbine—hematologic cancer	7.92e-05	0.000405	CcSEcCtD
Latanoprost—Dermatitis—Vinorelbine—hematologic cancer	7.92e-05	0.000404	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Epirubicin—hematologic cancer	7.9e-05	0.000404	CcSEcCtD
Latanoprost—Headache—Vinorelbine—hematologic cancer	7.87e-05	0.000402	CcSEcCtD
Latanoprost—Conjunctivitis—Methotrexate—hematologic cancer	7.87e-05	0.000402	CcSEcCtD
Latanoprost—Asthma—Doxorubicin—hematologic cancer	7.86e-05	0.000402	CcSEcCtD
Latanoprost—Oedema—Triamcinolone—hematologic cancer	7.82e-05	0.0004	CcSEcCtD
Latanoprost—Pruritus—Alitretinoin—hematologic cancer	7.82e-05	0.000399	CcSEcCtD
Latanoprost—Pruritus—Ifosfamide—hematologic cancer	7.72e-05	0.000395	CcSEcCtD
Latanoprost—Dyspnoea—Etoposide—hematologic cancer	7.69e-05	0.000393	CcSEcCtD
Latanoprost—Dizziness—Thalidomide—hematologic cancer	7.68e-05	0.000392	CcSEcCtD
Latanoprost—Angina pectoris—Doxorubicin—hematologic cancer	7.66e-05	0.000391	CcSEcCtD
Latanoprost—Erythema—Prednisone—hematologic cancer	7.57e-05	0.000387	CcSEcCtD
Latanoprost—Rash—Thiotepa—hematologic cancer	7.57e-05	0.000387	CcSEcCtD
Latanoprost—Bronchitis—Doxorubicin—hematologic cancer	7.56e-05	0.000386	CcSEcCtD
Latanoprost—Dermatitis—Thiotepa—hematologic cancer	7.56e-05	0.000386	CcSEcCtD
Latanoprost—Headache—Thiotepa—hematologic cancer	7.52e-05	0.000384	CcSEcCtD
Latanoprost—Dizziness—Carmustine—hematologic cancer	7.37e-05	0.000377	CcSEcCtD
Latanoprost—Pain—Etoposide—hematologic cancer	7.37e-05	0.000377	CcSEcCtD
Latanoprost—Conjunctivitis—Epirubicin—hematologic cancer	7.37e-05	0.000376	CcSEcCtD
Latanoprost—Urinary tract infection—Epirubicin—hematologic cancer	7.37e-05	0.000376	CcSEcCtD
Latanoprost—Rash—Thalidomide—hematologic cancer	7.32e-05	0.000374	CcSEcCtD
Latanoprost—Discomfort—Dexamethasone—hematologic cancer	7.31e-05	0.000374	CcSEcCtD
Latanoprost—Discomfort—Betamethasone—hematologic cancer	7.31e-05	0.000374	CcSEcCtD
Latanoprost—Dermatitis—Thalidomide—hematologic cancer	7.31e-05	0.000374	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Doxorubicin—hematologic cancer	7.31e-05	0.000373	CcSEcCtD
Latanoprost—Dizziness—Alitretinoin—hematologic cancer	7.3e-05	0.000373	CcSEcCtD
Latanoprost—Headache—Thalidomide—hematologic cancer	7.27e-05	0.000372	CcSEcCtD
Latanoprost—Pain—Prednisolone—hematologic cancer	7.27e-05	0.000372	CcSEcCtD
Latanoprost—Dizziness—Ifosfamide—hematologic cancer	7.22e-05	0.000369	CcSEcCtD
Latanoprost—Pruritus—Gemcitabine—hematologic cancer	7.14e-05	0.000365	CcSEcCtD
Latanoprost—Vision blurred—Prednisone—hematologic cancer	7.14e-05	0.000365	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	7.13e-05	0.000364	CcSEcCtD
Latanoprost—Oedema—Dexamethasone—hematologic cancer	7.1e-05	0.000363	CcSEcCtD
Latanoprost—Oedema—Betamethasone—hematologic cancer	7.1e-05	0.000363	CcSEcCtD
Latanoprost—Dizziness—Vincristine—hematologic cancer	7.04e-05	0.00036	CcSEcCtD
Latanoprost—Rash—Carmustine—hematologic cancer	7.03e-05	0.000359	CcSEcCtD
Latanoprost—Dermatitis—Carmustine—hematologic cancer	7.02e-05	0.000359	CcSEcCtD
Latanoprost—Headache—Carmustine—hematologic cancer	6.99e-05	0.000357	CcSEcCtD
Latanoprost—Dyspnoea—Triamcinolone—hematologic cancer	6.97e-05	0.000356	CcSEcCtD
Latanoprost—Rash—Alitretinoin—hematologic cancer	6.96e-05	0.000356	CcSEcCtD
Latanoprost—Nervous system disorder—Dexamethasone—hematologic cancer	6.96e-05	0.000356	CcSEcCtD
Latanoprost—Nervous system disorder—Betamethasone—hematologic cancer	6.96e-05	0.000356	CcSEcCtD
Latanoprost—Dermatitis—Alitretinoin—hematologic cancer	6.96e-05	0.000355	CcSEcCtD
Latanoprost—Headache—Alitretinoin—hematologic cancer	6.92e-05	0.000354	CcSEcCtD
Latanoprost—Rash—Ifosfamide—hematologic cancer	6.88e-05	0.000352	CcSEcCtD
Latanoprost—Dermatitis—Ifosfamide—hematologic cancer	6.88e-05	0.000351	CcSEcCtD
Latanoprost—Dizziness—Irinotecan—hematologic cancer	6.85e-05	0.00035	CcSEcCtD
Latanoprost—Conjunctivitis—Doxorubicin—hematologic cancer	6.82e-05	0.000348	CcSEcCtD
Latanoprost—Urinary tract infection—Doxorubicin—hematologic cancer	6.82e-05	0.000348	CcSEcCtD
Latanoprost—Rash—Vincristine—hematologic cancer	6.71e-05	0.000343	CcSEcCtD
Latanoprost—Dermatitis—Vincristine—hematologic cancer	6.71e-05	0.000343	CcSEcCtD
Latanoprost—Pain—Triamcinolone—hematologic cancer	6.69e-05	0.000342	CcSEcCtD
Latanoprost—Connective tissue disorder—Epirubicin—hematologic cancer	6.69e-05	0.000342	CcSEcCtD
Latanoprost—Headache—Vincristine—hematologic cancer	6.67e-05	0.000341	CcSEcCtD
Latanoprost—Mediastinal disorder—Methotrexate—hematologic cancer	6.55e-05	0.000335	CcSEcCtD
Latanoprost—Rash—Mitoxantrone—hematologic cancer	6.54e-05	0.000334	CcSEcCtD
Latanoprost—Rash—Irinotecan—hematologic cancer	6.54e-05	0.000334	CcSEcCtD
Latanoprost—Dermatitis—Mitoxantrone—hematologic cancer	6.53e-05	0.000334	CcSEcCtD
Latanoprost—Dermatitis—Irinotecan—hematologic cancer	6.53e-05	0.000334	CcSEcCtD
Latanoprost—Headache—Irinotecan—hematologic cancer	6.49e-05	0.000332	CcSEcCtD
Latanoprost—Headache—Mitoxantrone—hematologic cancer	6.49e-05	0.000332	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Betamethasone—hematologic cancer	6.47e-05	0.00033	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	6.47e-05	0.00033	CcSEcCtD
Latanoprost—Arthralgia—Prednisone—hematologic cancer	6.45e-05	0.000329	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	6.4e-05	0.000327	CcSEcCtD
Latanoprost—Discomfort—Prednisone—hematologic cancer	6.37e-05	0.000325	CcSEcCtD
Latanoprost—Rash—Gemcitabine—hematologic cancer	6.37e-05	0.000325	CcSEcCtD
Latanoprost—Dermatitis—Gemcitabine—hematologic cancer	6.36e-05	0.000325	CcSEcCtD
Latanoprost—Erythema—Methotrexate—hematologic cancer	6.33e-05	0.000323	CcSEcCtD
Latanoprost—Headache—Gemcitabine—hematologic cancer	6.33e-05	0.000323	CcSEcCtD
Latanoprost—Connective tissue disorder—Doxorubicin—hematologic cancer	6.19e-05	0.000316	CcSEcCtD
Latanoprost—Oedema—Prednisone—hematologic cancer	6.18e-05	0.000316	CcSEcCtD
Latanoprost—Mediastinal disorder—Epirubicin—hematologic cancer	6.13e-05	0.000313	CcSEcCtD
Latanoprost—Back pain—Methotrexate—hematologic cancer	6.12e-05	0.000313	CcSEcCtD
Latanoprost—Pruritus—Etoposide—hematologic cancer	6.1e-05	0.000312	CcSEcCtD
Latanoprost—Pain—Betamethasone—hematologic cancer	6.07e-05	0.00031	CcSEcCtD
Latanoprost—Pain—Dexamethasone—hematologic cancer	6.07e-05	0.00031	CcSEcCtD
Latanoprost—Nervous system disorder—Prednisone—hematologic cancer	6.06e-05	0.00031	CcSEcCtD
Latanoprost—Skin disorder—Prednisone—hematologic cancer	6e-05	0.000307	CcSEcCtD
Latanoprost—Vision blurred—Methotrexate—hematologic cancer	5.96e-05	0.000305	CcSEcCtD
Latanoprost—Rash—Cisplatin—hematologic cancer	5.93e-05	0.000303	CcSEcCtD
Latanoprost—Dermatitis—Cisplatin—hematologic cancer	5.93e-05	0.000303	CcSEcCtD
Latanoprost—Erythema—Epirubicin—hematologic cancer	5.92e-05	0.000303	CcSEcCtD
Latanoprost—Back pain—Epirubicin—hematologic cancer	5.73e-05	0.000293	CcSEcCtD
Latanoprost—Dizziness—Etoposide—hematologic cancer	5.7e-05	0.000291	CcSEcCtD
Latanoprost—Mediastinal disorder—Doxorubicin—hematologic cancer	5.67e-05	0.00029	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Prednisone—hematologic cancer	5.63e-05	0.000288	CcSEcCtD
Latanoprost—Dizziness—Prednisolone—hematologic cancer	5.62e-05	0.000287	CcSEcCtD
Latanoprost—PTGFR—Signaling by GPCR—PTGER4—hematologic cancer	5.59e-05	0.000986	CbGpPWpGaD
Latanoprost—Vision blurred—Epirubicin—hematologic cancer	5.58e-05	0.000285	CcSEcCtD
Latanoprost—PTGFR—Signaling Pathways—CCL17—hematologic cancer	5.56e-05	0.000979	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—AGRN—hematologic cancer	5.56e-05	0.000979	CbGpPWpGaD
Latanoprost—Pruritus—Triamcinolone—hematologic cancer	5.53e-05	0.000283	CcSEcCtD
Latanoprost—Erythema—Doxorubicin—hematologic cancer	5.48e-05	0.00028	CcSEcCtD
Latanoprost—PTGFR—Signaling Pathways—CXCR5—hematologic cancer	5.45e-05	0.000961	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—CXCR4—hematologic cancer	5.44e-05	0.000959	CbGpPWpGaD
Latanoprost—Rash—Etoposide—hematologic cancer	5.44e-05	0.000278	CcSEcCtD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—hematologic cancer	5.43e-05	0.000958	CbGpPWpGaD
Latanoprost—Dermatitis—Etoposide—hematologic cancer	5.43e-05	0.000277	CcSEcCtD
Latanoprost—Headache—Etoposide—hematologic cancer	5.4e-05	0.000276	CcSEcCtD
Latanoprost—Chest pain—Methotrexate—hematologic cancer	5.39e-05	0.000275	CcSEcCtD
Latanoprost—Arthralgia—Methotrexate—hematologic cancer	5.39e-05	0.000275	CcSEcCtD
Latanoprost—Rash—Prednisolone—hematologic cancer	5.36e-05	0.000274	CcSEcCtD
Latanoprost—Dermatitis—Prednisolone—hematologic cancer	5.36e-05	0.000274	CcSEcCtD
Latanoprost—PTGFR—Signaling Pathways—LEF1—hematologic cancer	5.36e-05	0.000944	CbGpPWpGaD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	5.35e-05	0.000273	CcSEcCtD
Latanoprost—Headache—Prednisolone—hematologic cancer	5.33e-05	0.000272	CcSEcCtD
Latanoprost—Discomfort—Methotrexate—hematologic cancer	5.32e-05	0.000272	CcSEcCtD
Latanoprost—Back pain—Doxorubicin—hematologic cancer	5.3e-05	0.000271	CcSEcCtD
Latanoprost—PTGFR—Signaling Pathways—GNA13—hematologic cancer	5.27e-05	0.000928	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—IL3—hematologic cancer	5.25e-05	0.000925	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—TIAM1—hematologic cancer	5.18e-05	0.000913	CbGpPWpGaD
Latanoprost—Dizziness—Triamcinolone—hematologic cancer	5.17e-05	0.000264	CcSEcCtD
Latanoprost—Vision blurred—Doxorubicin—hematologic cancer	5.16e-05	0.000264	CcSEcCtD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—PRKCG—hematologic cancer	5.16e-05	0.00091	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	5.14e-05	0.000906	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	5.12e-05	0.000903	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GMPS—hematologic cancer	5.09e-05	0.000897	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PHYH—hematologic cancer	5.09e-05	0.000897	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—FTCD—hematologic cancer	5.09e-05	0.000897	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—RASGRP1—hematologic cancer	5.07e-05	0.000894	CbGpPWpGaD
Latanoprost—Nervous system disorder—Methotrexate—hematologic cancer	5.06e-05	0.000259	CcSEcCtD
Latanoprost—PTGFR—GPCR ligand binding—CCL2—hematologic cancer	5.05e-05	0.000889	CbGpPWpGaD
Latanoprost—Chest pain—Epirubicin—hematologic cancer	5.04e-05	0.000258	CcSEcCtD
Latanoprost—Arthralgia—Epirubicin—hematologic cancer	5.04e-05	0.000258	CcSEcCtD
Latanoprost—PTGFR—Signaling Pathways—JAK3—hematologic cancer	5.02e-05	0.000886	CbGpPWpGaD
Latanoprost—Pruritus—Betamethasone—hematologic cancer	5.02e-05	0.000256	CcSEcCtD
Latanoprost—Pruritus—Dexamethasone—hematologic cancer	5.02e-05	0.000256	CcSEcCtD
Latanoprost—PTGFR—G alpha (q) signalling events—PIK3CA—hematologic cancer	5.02e-05	0.000884	CbGpPWpGaD
Latanoprost—Skin disorder—Methotrexate—hematologic cancer	5.02e-05	0.000256	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	5.01e-05	0.000256	CcSEcCtD
Latanoprost—Discomfort—Epirubicin—hematologic cancer	4.98e-05	0.000254	CcSEcCtD
Latanoprost—PTGFR—Signaling by GPCR—CXCR4—hematologic cancer	4.94e-05	0.000871	CbGpPWpGaD
Latanoprost—Rash—Triamcinolone—hematologic cancer	4.93e-05	0.000252	CcSEcCtD
Latanoprost—Dermatitis—Triamcinolone—hematologic cancer	4.93e-05	0.000252	CcSEcCtD
Latanoprost—Headache—Triamcinolone—hematologic cancer	4.9e-05	0.00025	CcSEcCtD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—hematologic cancer	4.88e-05	0.000861	CbGpPWpGaD
Latanoprost—Oedema—Epirubicin—hematologic cancer	4.83e-05	0.000247	CcSEcCtD
Latanoprost—PTGFR—Signaling Pathways—CXCL13—hematologic cancer	4.82e-05	0.000849	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CCR7—hematologic cancer	4.82e-05	0.000849	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—IL3—hematologic cancer	4.76e-05	0.00084	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NCOR2—hematologic cancer	4.75e-05	0.000838	CbGpPWpGaD
Latanoprost—Nervous system disorder—Epirubicin—hematologic cancer	4.74e-05	0.000242	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Methotrexate—hematologic cancer	4.71e-05	0.00024	CcSEcCtD
Latanoprost—Skin disorder—Epirubicin—hematologic cancer	4.69e-05	0.00024	CcSEcCtD
Latanoprost—PTGFR—Signaling Pathways—IL3RA—hematologic cancer	4.69e-05	0.000827	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CRKL—hematologic cancer	4.69e-05	0.000827	CbGpPWpGaD
Latanoprost—Dizziness—Betamethasone—hematologic cancer	4.69e-05	0.00024	CcSEcCtD
Latanoprost—Dizziness—Dexamethasone—hematologic cancer	4.69e-05	0.00024	CcSEcCtD
Latanoprost—Arthralgia—Doxorubicin—hematologic cancer	4.67e-05	0.000238	CcSEcCtD
Latanoprost—Chest pain—Doxorubicin—hematologic cancer	4.67e-05	0.000238	CcSEcCtD
Latanoprost—SLC22A1—Metabolism—SMPD3—hematologic cancer	4.66e-05	0.000821	CbGpPWpGaD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	4.63e-05	0.000237	CcSEcCtD
Latanoprost—Discomfort—Doxorubicin—hematologic cancer	4.61e-05	0.000235	CcSEcCtD
Latanoprost—PTGFR—Signaling by GPCR—RASGRP1—hematologic cancer	4.61e-05	0.000812	CbGpPWpGaD
Latanoprost—Dyspnoea—Methotrexate—hematologic cancer	4.6e-05	0.000235	CcSEcCtD
Latanoprost—PTGFR—GPCR downstream signaling—GRB2—hematologic cancer	4.56e-05	0.000804	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—RGS2—hematologic cancer	4.53e-05	0.000798	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	4.51e-05	0.000795	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—hematologic cancer	4.49e-05	0.000791	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—TRIO—hematologic cancer	4.48e-05	0.000789	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—TRH—hematologic cancer	4.48e-05	0.000789	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CMA1—hematologic cancer	4.48e-05	0.000789	CbGpPWpGaD
Latanoprost—Rash—Dexamethasone—hematologic cancer	4.47e-05	0.000229	CcSEcCtD
Latanoprost—Rash—Betamethasone—hematologic cancer	4.47e-05	0.000229	CcSEcCtD
Latanoprost—Oedema—Doxorubicin—hematologic cancer	4.47e-05	0.000228	CcSEcCtD
Latanoprost—Dermatitis—Betamethasone—hematologic cancer	4.47e-05	0.000228	CcSEcCtD
Latanoprost—Dermatitis—Dexamethasone—hematologic cancer	4.47e-05	0.000228	CcSEcCtD
Latanoprost—Headache—Dexamethasone—hematologic cancer	4.45e-05	0.000227	CcSEcCtD
Latanoprost—Headache—Betamethasone—hematologic cancer	4.45e-05	0.000227	CcSEcCtD
Latanoprost—Pain—Methotrexate—hematologic cancer	4.42e-05	0.000226	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Epirubicin—hematologic cancer	4.4e-05	0.000225	CcSEcCtD
Latanoprost—Nervous system disorder—Doxorubicin—hematologic cancer	4.39e-05	0.000224	CcSEcCtD
Latanoprost—PTGFR—Signaling Pathways—SPHK1—hematologic cancer	4.38e-05	0.000772	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—AGO2—hematologic cancer	4.38e-05	0.000772	CbGpPWpGaD
Latanoprost—Pruritus—Prednisone—hematologic cancer	4.37e-05	0.000223	CcSEcCtD
Latanoprost—Skin disorder—Doxorubicin—hematologic cancer	4.34e-05	0.000222	CcSEcCtD
Latanoprost—PTGFR—Signaling Pathways—HDAC9—hematologic cancer	4.34e-05	0.000765	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—LPAR1—hematologic cancer	4.34e-05	0.000765	CbGpPWpGaD
Latanoprost—Dyspnoea—Epirubicin—hematologic cancer	4.31e-05	0.00022	CcSEcCtD
Latanoprost—PTGFR—Signaling Pathways—H3F3B—hematologic cancer	4.29e-05	0.000757	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—hematologic cancer	4.15e-05	0.000732	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—GRB2—hematologic cancer	4.14e-05	0.00073	CbGpPWpGaD
Latanoprost—Pain—Epirubicin—hematologic cancer	4.13e-05	0.000211	CcSEcCtD
Latanoprost—Dizziness—Prednisone—hematologic cancer	4.09e-05	0.000209	CcSEcCtD
Latanoprost—PTGFR—GPCR downstream signaling—CSF2—hematologic cancer	4.08e-05	0.000719	CbGpPWpGaD
Latanoprost—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	4.07e-05	0.000208	CcSEcCtD
Latanoprost—SLC22A1—Metabolism—B3GAT1—hematologic cancer	4.07e-05	0.000717	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—DCK—hematologic cancer	4.07e-05	0.000717	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ASNS—hematologic cancer	4.07e-05	0.000717	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CNR2—hematologic cancer	3.99e-05	0.000704	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PDE4B—hematologic cancer	3.99e-05	0.000704	CbGpPWpGaD
Latanoprost—Dyspnoea—Doxorubicin—hematologic cancer	3.99e-05	0.000204	CcSEcCtD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hematologic cancer	3.97e-05	0.0007	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—FGF19—hematologic cancer	3.96e-05	0.000698	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—PRKCG—hematologic cancer	3.96e-05	0.000697	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—JAK1—hematologic cancer	3.93e-05	0.000694	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—PRKCG—hematologic cancer	3.93e-05	0.000694	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—RAC2—hematologic cancer	3.93e-05	0.000692	CbGpPWpGaD
Latanoprost—Rash—Prednisone—hematologic cancer	3.9e-05	0.000199	CcSEcCtD
Latanoprost—PTGFR—Signaling Pathways—DKK1—hematologic cancer	3.9e-05	0.000687	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—NUP98—hematologic cancer	3.9e-05	0.000687	CbGpPWpGaD
Latanoprost—Dermatitis—Prednisone—hematologic cancer	3.89e-05	0.000199	CcSEcCtD
Latanoprost—Headache—Prednisone—hematologic cancer	3.87e-05	0.000198	CcSEcCtD
Latanoprost—PTGFR—Signaling Pathways—STAT5B—hematologic cancer	3.87e-05	0.000681	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—HDC—hematologic cancer	3.86e-05	0.00068	CbGpPWpGaD
Latanoprost—Pain—Doxorubicin—hematologic cancer	3.82e-05	0.000195	CcSEcCtD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—CREB1—hematologic cancer	3.82e-05	0.000674	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	3.78e-05	0.000667	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—BRAF—hematologic cancer	3.78e-05	0.000666	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—NUP214—hematologic cancer	3.75e-05	0.000662	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—ADCY7—hematologic cancer	3.75e-05	0.000662	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CSF2—hematologic cancer	3.7e-05	0.000653	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	3.68e-05	0.000648	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—IL2RA—hematologic cancer	3.67e-05	0.000648	CbGpPWpGaD
Latanoprost—Pruritus—Methotrexate—hematologic cancer	3.65e-05	0.000187	CcSEcCtD
Latanoprost—PTGFR—Signaling Pathways—XIAP—hematologic cancer	3.65e-05	0.000644	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—JAK1—hematologic cancer	3.57e-05	0.00063	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PRKCG—hematologic cancer	3.57e-05	0.00063	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—SH2B3—hematologic cancer	3.56e-05	0.000627	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—SMARCA4—hematologic cancer	3.56e-05	0.000627	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—GZMB—hematologic cancer	3.54e-05	0.000623	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CDA—hematologic cancer	3.53e-05	0.000622	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CTNNA1—hematologic cancer	3.45e-05	0.000609	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—EIF4EBP1—hematologic cancer	3.43e-05	0.000605	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—HSPB1—hematologic cancer	3.43e-05	0.000605	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CCL3—hematologic cancer	3.43e-05	0.000605	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.42e-05	0.000604	CbGpPWpGaD
Latanoprost—Pruritus—Epirubicin—hematologic cancer	3.42e-05	0.000175	CcSEcCtD
Latanoprost—Dizziness—Methotrexate—hematologic cancer	3.42e-05	0.000174	CcSEcCtD
Latanoprost—SLC22A1—Metabolism—PC—hematologic cancer	3.4e-05	0.000599	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—SDC1—hematologic cancer	3.39e-05	0.000598	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PTHLH—hematologic cancer	3.39e-05	0.000598	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—IL2RA—hematologic cancer	3.34e-05	0.000588	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PTGER4—hematologic cancer	3.3e-05	0.000582	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—LCK—hematologic cancer	3.29e-05	0.000579	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GBA—hematologic cancer	3.28e-05	0.000578	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—SLC35B2—hematologic cancer	3.28e-05	0.000578	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—TFRC—hematologic cancer	3.28e-05	0.000578	CbGpPWpGaD
Latanoprost—Rash—Methotrexate—hematologic cancer	3.26e-05	0.000166	CcSEcCtD
Latanoprost—Dermatitis—Methotrexate—hematologic cancer	3.25e-05	0.000166	CcSEcCtD
Latanoprost—Headache—Methotrexate—hematologic cancer	3.24e-05	0.000165	CcSEcCtD
Latanoprost—PTGFR—Signaling Pathways—H3F3A—hematologic cancer	3.22e-05	0.000568	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—ALB—hematologic cancer	3.21e-05	0.000565	CbGpPWpGaD
Latanoprost—Dizziness—Epirubicin—hematologic cancer	3.2e-05	0.000163	CcSEcCtD
Latanoprost—Pruritus—Doxorubicin—hematologic cancer	3.16e-05	0.000162	CcSEcCtD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—MDM2—hematologic cancer	3.16e-05	0.000558	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PRKCZ—hematologic cancer	3.13e-05	0.000552	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—PIK3CG—hematologic cancer	3.06e-05	0.00054	CbGpPWpGaD
Latanoprost—Rash—Epirubicin—hematologic cancer	3.05e-05	0.000156	CcSEcCtD
Latanoprost—Dermatitis—Epirubicin—hematologic cancer	3.04e-05	0.000156	CcSEcCtD
Latanoprost—Headache—Epirubicin—hematologic cancer	3.03e-05	0.000155	CcSEcCtD
Latanoprost—PTGFR—Signaling Pathways—PARP1—hematologic cancer	3.02e-05	0.000533	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—MTAP—hematologic cancer	3e-05	0.000529	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—FBXW7—hematologic cancer	2.98e-05	0.000525	CbGpPWpGaD
Latanoprost—Dizziness—Doxorubicin—hematologic cancer	2.96e-05	0.000151	CcSEcCtD
Latanoprost—SLC22A1—Neuronal System—CREB1—hematologic cancer	2.93e-05	0.000516	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—HDAC2—hematologic cancer	2.92e-05	0.000514	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CXCR4—hematologic cancer	2.92e-05	0.000514	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—BRAF—hematologic cancer	2.89e-05	0.00051	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CBL—hematologic cancer	2.84e-05	0.000501	CbGpPWpGaD
Latanoprost—SLC22A1—SLC-mediated transmembrane transport—ALB—hematologic cancer	2.83e-05	0.000498	CbGpPWpGaD
Latanoprost—Rash—Doxorubicin—hematologic cancer	2.82e-05	0.000144	CcSEcCtD
Latanoprost—Dermatitis—Doxorubicin—hematologic cancer	2.82e-05	0.000144	CcSEcCtD
Latanoprost—PTGFR—Signaling Pathways—IL3—hematologic cancer	2.81e-05	0.000496	CbGpPWpGaD
Latanoprost—Headache—Doxorubicin—hematologic cancer	2.8e-05	0.000143	CcSEcCtD
Latanoprost—PTGFR—Signaling by GPCR—PIK3CG—hematologic cancer	2.78e-05	0.00049	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PTPN1—hematologic cancer	2.77e-05	0.000488	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—CYCS—hematologic cancer	2.75e-05	0.000485	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PTPN11—hematologic cancer	2.73e-05	0.000481	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—RASGRP1—hematologic cancer	2.72e-05	0.00048	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—SYK—hematologic cancer	2.71e-05	0.000478	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—HSP90AA1—hematologic cancer	2.71e-05	0.000478	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—PIK3CD—hematologic cancer	2.69e-05	0.000474	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—FHL2—hematologic cancer	2.67e-05	0.000471	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CREB1—hematologic cancer	2.65e-05	0.000466	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—AGRN—hematologic cancer	2.62e-05	0.000462	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—STAT1—hematologic cancer	2.62e-05	0.000461	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CCL2—hematologic cancer	2.59e-05	0.000456	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—IL6R—hematologic cancer	2.58e-05	0.000455	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—PIK3R1—hematologic cancer	2.54e-05	0.000448	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—IDH2—hematologic cancer	2.49e-05	0.000438	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—HMMR—hematologic cancer	2.49e-05	0.000438	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—JAK2—hematologic cancer	2.47e-05	0.000435	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—MAP2K1—hematologic cancer	2.46e-05	0.000434	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—GRB2—hematologic cancer	2.45e-05	0.000431	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PIK3CD—hematologic cancer	2.44e-05	0.000431	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PDGFA—hematologic cancer	2.44e-05	0.00043	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—MDM2—hematologic cancer	2.42e-05	0.000427	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—KITLG—hematologic cancer	2.41e-05	0.000424	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—STAT5A—hematologic cancer	2.35e-05	0.000415	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—PIK3CB—hematologic cancer	2.35e-05	0.000414	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ARNTL—hematologic cancer	2.34e-05	0.000412	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CDKN2B—hematologic cancer	2.33e-05	0.000411	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PIK3R1—hematologic cancer	2.31e-05	0.000407	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	2.3e-05	0.000405	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ACP5—hematologic cancer	2.27e-05	0.000401	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CA9—hematologic cancer	2.27e-05	0.000401	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CD86—hematologic cancer	2.26e-05	0.000398	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—NCOR2—hematologic cancer	2.24e-05	0.000396	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—JAK2—hematologic cancer	2.24e-05	0.000395	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—HES1—hematologic cancer	2.22e-05	0.000392	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NCOR1—hematologic cancer	2.21e-05	0.00039	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CSF2—hematologic cancer	2.19e-05	0.000386	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—FGF1—hematologic cancer	2.19e-05	0.000386	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—FOXO1—hematologic cancer	2.16e-05	0.00038	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—IL2—hematologic cancer	2.15e-05	0.00038	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PDGFRB—hematologic cancer	2.15e-05	0.000379	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—IDH1—hematologic cancer	2.14e-05	0.000377	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PIK3CB—hematologic cancer	2.13e-05	0.000376	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PDGFRA—hematologic cancer	2.12e-05	0.000373	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTO1—hematologic cancer	2.11e-05	0.000373	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—TXN—hematologic cancer	2.11e-05	0.000373	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ABCC3—hematologic cancer	2.11e-05	0.000373	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PRKCG—hematologic cancer	2.11e-05	0.000372	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—JAK1—hematologic cancer	2.11e-05	0.000372	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—SPHK1—hematologic cancer	2.07e-05	0.000365	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—UGT1A1—hematologic cancer	1.99e-05	0.00035	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IL2RA—hematologic cancer	1.97e-05	0.000347	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—IL2—hematologic cancer	1.96e-05	0.000345	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—TERT—hematologic cancer	1.95e-05	0.000344	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CRABP1—hematologic cancer	1.93e-05	0.000341	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PDGFB—hematologic cancer	1.9e-05	0.000335	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ALOX5—hematologic cancer	1.88e-05	0.000332	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—TSC2—hematologic cancer	1.86e-05	0.000328	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—NUP98—hematologic cancer	1.82e-05	0.000322	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—FGFR3—hematologic cancer	1.79e-05	0.000315	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ADCY7—hematologic cancer	1.77e-05	0.000312	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—NCOA3—hematologic cancer	1.77e-05	0.000312	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MAPK14—hematologic cancer	1.77e-05	0.000312	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—NUP214—hematologic cancer	1.76e-05	0.00031	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—ESR1—hematologic cancer	1.74e-05	0.000306	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—HRAS—hematologic cancer	1.74e-05	0.000306	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ABCG2—hematologic cancer	1.72e-05	0.000304	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—MTR—hematologic cancer	1.72e-05	0.000304	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—FN1—hematologic cancer	1.72e-05	0.000303	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—BAD—hematologic cancer	1.7e-05	0.000299	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NFKBIA—hematologic cancer	1.7e-05	0.000299	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ENO2—hematologic cancer	1.69e-05	0.000298	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NOTCH1—hematologic cancer	1.68e-05	0.000296	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CD80—hematologic cancer	1.65e-05	0.00029	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—KIT—hematologic cancer	1.64e-05	0.000289	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PIK3CG—hematologic cancer	1.64e-05	0.000289	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—NRAS—hematologic cancer	1.64e-05	0.000289	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTT1—hematologic cancer	1.64e-05	0.000289	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PTPN11—hematologic cancer	1.61e-05	0.000284	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—SDC1—hematologic cancer	1.6e-05	0.000282	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—MAPK3—hematologic cancer	1.57e-05	0.000277	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CREB1—hematologic cancer	1.56e-05	0.000276	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—BRAF—hematologic cancer	1.54e-05	0.000272	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.53e-05	0.00027	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CCL2—hematologic cancer	1.53e-05	0.00027	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IL6R—hematologic cancer	1.52e-05	0.000269	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CREBBP—hematologic cancer	1.52e-05	0.000268	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MAP2K1—hematologic cancer	1.45e-05	0.000256	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PIK3CD—hematologic cancer	1.44e-05	0.000254	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—ALB—hematologic cancer	1.44e-05	0.000253	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—PIK3CA—hematologic cancer	1.43e-05	0.000252	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—KRAS—hematologic cancer	1.41e-05	0.000249	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—FGF2—hematologic cancer	1.38e-05	0.000244	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PIK3R1—hematologic cancer	1.36e-05	0.00024	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CD44—hematologic cancer	1.36e-05	0.00024	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—NQO1—hematologic cancer	1.36e-05	0.00024	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—HRAS—hematologic cancer	1.33e-05	0.000234	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—JAK2—hematologic cancer	1.32e-05	0.000234	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PIK3CA—hematologic cancer	1.3e-05	0.000229	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MDM2—hematologic cancer	1.29e-05	0.000228	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYCS—hematologic cancer	1.29e-05	0.000227	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—HSP90AA1—hematologic cancer	1.28e-05	0.000226	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PIK3CB—hematologic cancer	1.26e-05	0.000222	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MTOR—hematologic cancer	1.26e-05	0.000222	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—HRAS—hematologic cancer	1.2e-05	0.000212	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CDKN1B—hematologic cancer	1.18e-05	0.000208	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—AKT1—hematologic cancer	1.17e-05	0.000206	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CASP3—hematologic cancer	1.16e-05	0.000204	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IL2—hematologic cancer	1.16e-05	0.000204	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—IL6—hematologic cancer	1.15e-05	0.000203	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTP1—hematologic cancer	1.14e-05	0.0002	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CCND1—hematologic cancer	1.13e-05	0.000199	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—JUN—hematologic cancer	1.12e-05	0.000198	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CDKN1A—hematologic cancer	1.09e-05	0.000192	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PTEN—hematologic cancer	1.09e-05	0.000192	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ABCB1—hematologic cancer	1.08e-05	0.00019	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MAPK8—hematologic cancer	1.06e-05	0.000188	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—AKT1—hematologic cancer	1.06e-05	0.000187	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—NCOR1—hematologic cancer	1.04e-05	0.000184	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTM1—hematologic cancer	1.04e-05	0.000184	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—EP300—hematologic cancer	1.04e-05	0.000183	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—SRC—hematologic cancer	1.01e-05	0.000178	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—VEGFA—hematologic cancer	9.82e-06	0.000173	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—STAT3—hematologic cancer	9.72e-06	0.000171	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NRAS—hematologic cancer	9.7e-06	0.000171	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MAPK3—hematologic cancer	9.29e-06	0.000164	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—MTHFR—hematologic cancer	9.23e-06	0.000163	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MYC—hematologic cancer	9.04e-06	0.000159	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—TGFB1—hematologic cancer	9.01e-06	0.000159	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—KRAS—hematologic cancer	8.35e-06	0.000147	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PIK3CG—hematologic cancer	7.75e-06	0.000137	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PIK3CA—hematologic cancer	7.67e-06	0.000135	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—TP53—hematologic cancer	7.42e-06	0.000131	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CREBBP—hematologic cancer	7.19e-06	0.000127	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—HRAS—hematologic cancer	7.1e-06	0.000125	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PIK3CD—hematologic cancer	6.81e-06	0.00012	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IL6—hematologic cancer	6.79e-06	0.00012	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ALB—hematologic cancer	6.73e-06	0.000119	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PIK3R1—hematologic cancer	6.43e-06	0.000113	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—AKT1—hematologic cancer	6.27e-06	0.00011	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PIK3CB—hematologic cancer	5.94e-06	0.000105	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PTEN—hematologic cancer	5.13e-06	9.05e-05	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—EP300—hematologic cancer	4.89e-06	8.63e-05	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PIK3CA—hematologic cancer	3.62e-06	6.38e-05	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—AKT1—hematologic cancer	2.96e-06	5.21e-05	CbGpPWpGaD
